“人才版图”引领 绘就生物医药千亿“产业蓝图”

经济参考报
Aug 14

研发出首个幽门螺杆菌创新药的丹诺医药成功登陆香港联交所,用于治疗胃癌的1类创新药安尼妥单抗注射液正式获批上市,精神分裂症治疗创新药凯捷乐从苏州首发销往全国……今年以来,苏州工业园区生物医药板块“捷报”频传。  生物医药创新成果竞相涌现的背后,离不开引领产业发展的人才支撑。记者日前在苏州工业园区采访了解到,当地以一场跨越20年的接力打造“人才版图”,造就产才融合的良性生态,引领生物医药千亿“产业蓝图...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10